scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Hematological parameters and protein metabolism in the blood of pregnant rats under the effect of vanadium citrate

TL;DR: Vanadium citrate normalizes the indicators of protein metabolism during pregnancy, thus it can be considered as a potential dietary drug for the pregnant.
Abstract: Dose-dependent changes in protein metabolism in the blood and hematological parameters of pregnant rats under the effect of vanadium citrate are presented in the article. The animals were divided into five groups: group I – non-pregnant females, II – pregnant females consuming pure water without additives, III, IV, V – females which during the mating and pregnancy period received the solution of vanadium citrate at concentrations of 0.03, 0.125 and 0.50 μg V/mL water. The research findings show that in pregnant animals of group II, the level of urea and alkaline phosphatase activity increased, meanwhile aspartate aminotransferase activity decreased, as compared to the non-pregnant females of group І. The levels of total protein and albumin decreased; however, the content of β-globulins increased in the pregnant animals of group II, as compared with that in group I. Also, in the rats of group II, there was a decrease in hemolysis time, total content of erythrocytes and hemoglobin, the content of old and mature erythrocytes, while the content of young erythrocytes increased, as compared to group I. The platelet content and thrombocrit in rats of group II increased in comparison with group I. The content of leukocytes and lymphocytes in pregnant animals of group II decreased, while the content of granulocytes increased, in contrast to non-pregnant rats. Under the effect of vanadium citrate at concentrations of 0.03–0.50 μg V/mL, there was a significant increase in the maximum number of prohemolized erythrocytes, the time of maximum hemolysis was delayed by 0.4–0.6 min, as compared with the pregnant rats of group II. This did not affect the time of total hemolysis in rats of groups III and V, as compared with the pregnant animals in group II. Under the effect of vanadium citrate, an increase in the content of young erythrocytes was observed, as compared with group II. The hemoglobin content decreased at the concentration of 0.125 μg V/mL, while at the concentration of 0.50 μg V/mL it increased, as compared to the pregnant animals of group II. Also, under the effect of vanadium citrate there was a decrease in the mean hemoglobin concentration in the erythrocyte. In pregnant animals fed with vanadium citrate solutions, the platelet content and thrombocrit, the relative width of platelet distribution by volume decreased, as compared with the pregnant rats of group II. The content of leukocytes, lymphocytes and granulocytes under the effect of vanadium citrate increased, as compared with the pregnant animals in group II. Under the effect of vanadium citrate at the concentration of 0.03 μg V/mL, the level of albumin, creatinine and aspartate aminotransferase activity increased in blood plasma in comparison with group II. Meanwhile, at the concentration of 0.125 μg V/mL, the relative content of γ-globulins and aspartate aminotransferase activity increased, alkaline phosphatase activity and urea level decreased in comparison with group II. However at the concentration of 0.50 μg V/mL, the relative α- and γ-globulins content and aspartate aminotransferase activity increased, at the same time, the relative β-globulins content and urea level decreased in comparison with group II. Therefore, vanadium citrate normalizes the indicators of protein metabolism during pregnancy, thus it can be considered as a potential dietary drug for the pregnant.

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI
TL;DR: The effects of vanadium pentoxide (V2O5) on hematological, oxidative stress biomarkers, and histopathological status of male Oryctolagus cuniculus were investigated on a 21-day exposure trial and 7-days recovery as mentioned in this paper .
Abstract: The effects of vanadium pentoxide (V2O5) on hematological, oxidative stress biomarkers, and histopathological status of male Oryctolagus cuniculus were investigated on a 21-day exposure trial and 7-days recovery. Oryctolagus cuniculus (433.45 ± 5.00 g) were randomized into four experimental and one control groups each in triplicate of four animals. A 96-h estimated median lethal dose (LD50) of 119.0 mg/kg was used to derive four experimental daily oral doses (1, 5, 10 and 20 mg/kg body weight) of V2O5; while the control received distilled water instead. Hematological and oxidative stress biomarkers were evaluated on day-7 (d-7), d-14, d-21 and 7-d withdrawal, whereas histopathology was assessed on d-21 and 7-d withdrawal. After 21-d exposure to 20 mg/kg of V2O5, the red blood cell count (RBC) and hemoglobin concentration (Hb) decreased by 16.9% and 12.3% respectively, while the white blood cell count (WBC) increased by 6.7% compared to the control. The activities of catalase and superoxide dismutase decreased by as much as 30.0% and 14.3% respectively compared to the control in rabbits exposed to 20 mg/kg of V2O5. Lipid peroxidation increased from exposure to V2O5, and peaked on d-7 (∼ 42.9 – 61.0% above the control). Changes in oxidative stress biomarkers were dose- and time-dependent. Sections of the liver and kidney of exposed animals showed alterations in tissue architecture that were characterized by inflammatory cells infiltration, sinusoidal congestion, renal cast formation and vacuolar and tubular degeneration. Taken together, exposure to V2O5 exerts hematological, oxidative stress and histopathological changes in O. cuniculus and calls for strict restriction on the use of this compound to avert environmental hazard.

3 citations

References
More filters
Journal ArticleDOI
TL;DR: Recommendations of the National Committee for Clinical Laboratory Standards continue to be based on this publication; the “Kirby-Bauer” method is, among the many disk methods used in other countries, still the one that has been researched most thoroughly and updated continuously.
Abstract: In the words of the authors, the paper by A. W. Bauer et al., from the University of Washington in Seattle, on a standardized single-disk method for antibiotic susceptibility testing “. . . consolidate(s) and update(s) previous descriptions of the method and provide(s) a concise outline for its performance and interpretation.” Clinical microbiologists were relieved that finally a disk diffusion method had been standardized, could be used with ease, and provided reliable results as compared with minimum inhibitory concentration tests. The pivotal role of Hans Ericsson’s theoretical and practical studies (H. Ericsson and G. Svartz-Malmberg, Antibiot. Chemother. 6:41–74, 1959), as well as earlier reports by some of the authors of the publications cited, must be mentioned as a matter of fairness. Most of the recommendations given are still valid today even though some of the antimicrobial agents are obsolete, new ones have been added, some zone sizes had to be modified, and new media were designed for Haemophilus influenzae and Neisseria gonorrhoeae. Recommendations of the National Committee for Clinical Laboratory Standards continue to be based on this publication; the “Kirby-Bauer” method is, among the many disk methods used in other countries, still the one that has been researched most thoroughly and updated continuously. ALEXANDER VON GRAEVENITZ

16,916 citations


"Hematological parameters and protei..." refers methods in this paper

  • ...Antibacterial resistance in staphylococci was determined using the disc-diffusion method on Mueller-Hinton agar according to Clinical and Laboratory Standards Institute Guidelines (Bauer et al., 1966; Clinical Laboratory Standards Institute, 2014)....

    [...]

Journal ArticleDOI
TL;DR: In this paper, the authors present an overview of the current knowledge of the determinants (both human and bacterial) and risks of S aureus nasal carriage, and summarise the population dynamics of SA.
Abstract: Staphylococcus aureus is a frequent cause of infections in both the community and hospital. Worldwide, the increasing resistance of this pathogen to various antibiotics complicates treatment of S aureus infections. Effective measures to prevent S aureus infections are therefore urgently needed. It has been shown that nasal carriers of S aureus have an increased risk of acquiring an infection with this pathogen. The nose is the main ecological niche where S aureus resides in human beings, but the determinants of the carrier state are incompletely understood. Eradication of S aureus from nasal carriers prevents infection in specific patient categories-eg, haemodialysis and general surgery patients. However, recent randomised clinical trials in orthopaedic and non-surgical patients failed to show the efficacy of eliminating S aureus from the nose to prevent subsequent infection. Thus we must elucidate the mechanisms behind S aureus nasal carriage and infection to be able to develop new preventive strategies. We present an overview of the current knowledge of the determinants (both human and bacterial) and risks of S aureus nasal carriage. Studies on the population dynamics of S aureus are also summarised.

2,280 citations

Journal ArticleDOI
TL;DR: A strain of staphylococci in becoming resistant to penicillin did not show an increase in its resistance to sulfactin and the increase in resistance developed by a strain of E. coli to streptomycin was intermediate.
Abstract: SummaryA strain of staphylococci in becoming resistant to penicillin did not show an increase in its resistance to sulfactin. A similar strain of staphylococci in becoming resistant to sulfactin di...

1,941 citations


"Hematological parameters and protei..." refers background in this paper

  • ...The nose is considered the most frequent localization of S. aureus (Wertheim et al., 2005; Brown et al., 2014)....

    [...]

Book
01 Jan 2010
TL;DR: The tabular information presented here represents the most current information for drug selection, interpretation, and quality control using the procedures standardized in M02 and M07, and users should replace the tables published earlier with these new tables.
Abstract: The supplemental information presented in this document is intended for use with the antimicrobial susceptibility testing procedures published in the following Clinical and Laboratory Standards Institute (CLSI)–approved standards: M02-A10—Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Tenth Edition; and M07-A8—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Eighth Edition. The standards contain information about both disk (M02) and dilution (M07) test procedures for aerobic bacteria. Clinicians depend heavily on information from the clinical microbiology laboratory for treatment of their seriously ill patients. The clinical importance of antimicrobial susceptibility test results requires that these tests be performed under optimal conditions and that laboratories have the capability to provide results for the newest antimicrobial agents. The tabular information presented here represents the most current information for drug selection, interpretation, and quality control using the procedures standardized in M02 and M07. Users should replace the tables published earlier with these new tables. (Changes in the tables since the most current edition appear in boldface type.) Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. CLSI document M100-S21 (ISBN 1-56238-742-1). Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087 USA, 2011. The data in the interpretive tables in this supplement are valid only if the methodologies in M02-A10—Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Tenth Edition; and M07-A8—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Eighth Edition are followed. January 2011 M100-S21

1,478 citations

Journal ArticleDOI
TL;DR: This review will focus on the emergence of antimicrobial resistance in S. aureus, the leading overall cause of nosocomial infections and, as more patients are treated outside the hospital setting, is an increasing concern in the community.
Abstract: In the early 1970s, physicians were finally forced to abandon their belief that, given the vast array of effective antimicrobial agents, virtually all bacterial infections were treatable. Their optimism was shaken by the emergence of resistance to multiple antibiotics among such pathogens as Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa, and Mycobacterium tuberculosis. The evolution of increasingly antimicrobial-resistant bacterial species stems from a multitude of factors that includes the widespread and sometimes inappropriate use of antimicrobials, the extensive use of these agents as growth enhancers in animal feed, and, with the increase in regional and international travel, the relative ease with which antimicrobial-resistant bacteria cross geographic barriers (1–3). The irony of this trend toward progressively more resistant bacteria is that it coincides with a period of dramatically increased understanding of the molecular mechanisms of antimicrobial resistance. Unfortunately, while this insight has resulted in the identification of novel drug targets, it has not yet resulted in effective new chemotherapeutic agents. This paradox stands in sharp contrast to the dramatic progress made in antiviral (notably antiretroviral) therapy in the past ten years, where a number of newly discovered molecular targets have resulted in clinically effective therapeutic agents. Nowhere has this issue been of greater concern than with the Gram-positive bacteria pneumococci, enterococci, and staphylococci. Multidrug resistance is now the norm among these pathogens. S. aureus is perhaps the pathogen of greatest concern because of its intrinsic virulence, its ability to cause a diverse array of life-threatening infections, and its capacity to adapt to different environmental conditions (4, 5). The mortality of S. aureus bacteremia remains approximately 20–40% despite the availability of effective antimicrobials (6). S. aureus is now the leading overall cause of nosocomial infections and, as more patients are treated outside the hospital setting, is an increasing concern in the community (7, 8). S. aureus isolates from intensive care units across the country and from blood culture isolates worldwide are increasingly resistant to a greater number of antimicrobial agents (4, 8). Inevitably this has left fewer effective bactericidal antibiotics to treat these often life-threatening infections (Figure ​(Figure1).1). As rapidly as new antibiotics are introduced, staphylococci have developed efficient mechanisms to neutralize them (Table ​(Table11). Figure 1 S. aureus infections in intensive care units in the National Nosocomial Infections Surveillance System. Data include the total number of infections from 1987 to 1997. Isolates were tested for sensitivity to the following antimicrobial agents: gentamicin, ... Table 1 Mechanisms of S. aureus resistance to antimicrobialsA Recent reports of S. aureus isolates with intermediate or complete resistance to vancomycin portend a chemotherapeutic era in which effective bactericidal antibiotics against this organism may no longer be readily available (9, 10). This review will focus on the emergence of antimicrobial resistance in S. aureus. It will review the historical evolution of resistant strains, their spread, the molecular mechanisms of resistance for selected antibiotics, and progress toward the development of alternative drug targets or novel approaches for therapeutic or prophylactic intervention.

1,382 citations


"Hematological parameters and protei..." refers background in this paper

  • ...In that case, S. aureus is influenced by sub-therapeutic concentrations of drugs, which may cause mutations (Lowy, 2003)....

    [...]